Latest

AstraZeneca moves some production to US amid tariff threat
AstraZeneca moves some production to US amid tariff threat
Economy
by  AFP

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector. Other pharmaceutical companies have also announced plans to increase investments in the United States.

Pfizer profits dip on lower Paxlovid sales
Pfizer profits dip on lower Paxlovid sales
Economy
by  AFP

Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects. Sales of Paxlovid slid 75 percent amid lower Covid-19 infections and reduced government purchases of the medication.